State-by-state availability specific to the Longevity service wasn't established in the materials reviewed for this article, either - the brand's Terms only confirm that services are U.S.-only and may be limited by state law or Clinical Partner availability
Solubility recommendations based on peptide charge and hydrophobicity, suggesting use of dilute acetic acid for basic peptides, dilute base for acidic peptides, or addition of organic solvents (DMSO/DMF) for highly hydrophobic or aggregating peptides to achieve the desired concentration

Alternative 20-day extended protocol Extended cycle approach: Duration: 20 consecutive days Dose: 5-10mg per day Total: 100-200mg per cycle Frequency: Every 6-12 months Goal: Deeper, more sustained effects Why 20 days: Allows more comprehensive cellular changes Telomere lengthening may be more pronounced Some users report stronger anti-aging benefits Less frequent cycling (only 1-2x per year) Higher total peptide investment 20-day protocol comparison: Who uses 20-day protocol: Users wanting longer cycles with less frequent dosing Those who respond well to extended peptide therapy Individuals combining with other anti-aging interventions People who prefer fewer total cycles Potential advantages: May produce more sustained benefits Fewer cycles = less injection burden Possibly stronger gene expression changes Some report better sleep normalization Potential disadvantages: Higher per-cycle cost More injection days consecutively Less opportunity to assess response before next cycle No evidence it's superior to 10-day protocol Learn about cycling different peptides at SeekPeptides

Notably, GC exhibits higher tissue heterogeneity and invasive potential than other solid malignancies 7
I called around and found a clinic in Florida that provided CJC 1295 with Ipamorelin